Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-16
2010-06-15
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S217000, C548S306100, C548S466000, C548S178000, C548S525000, C548S203000, C548S222000, C514S367000, C514S414000, C514S422000, C514S394000, C514S210210, C514S321000, C514S365000, C514S338000, C514S233800, C514S254020, C514S255050, C546S198000, C546S271700, C544S137000, C544S368000, C544S405000
Reexamination Certificate
active
07737166
ABSTRACT:
A 1,6-β-glucan synthetase inhibitor is provided, having potent growth inhibition and having excellent safety. A compound is provided, capable of expressing in a wide spectral range and specifically or selectively, an antifungal effect based on its functional mechanism of 1,6-β-glucan synthesis inhibition. Also provided is a drug, a salt or hydrate thereof, especially an antifungal that contains the compound. Concretely, provided is a compound of the following formula (I), its salt or hydrate, and a drug or antifungal containing, as the active ingredient, the compound, its salt or hydrate:
REFERENCES:
patent: 6376449 (2002-04-01), Olsen
patent: 6376491 (2002-04-01), Aoki et al.
patent: 6555569 (2003-04-01), Sutcliffe et al.
patent: 7037932 (2006-05-01), Gallagher et al.
patent: 2001/0046985 (2001-11-01), Sutcliffe et al.
patent: 2004/0018192 (2004-01-01), Wakabayashi et al.
patent: 2004/0176435 (2004-09-01), Gallagher et al.
patent: 2005/0176712 (2005-08-01), Wakabayashi et al.
patent: 03022850 (2003-03-01), None
patent: 03064422 (2003-08-01), None
patent: 2004098494 (2004-11-01), None
patent: WO 2004098494 (2004-11-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, pp. 205-213.
Vippagunta et al. Advanced Drug Delivery Reviews, 48 (2001), pp. 3-26.
Souillac, et al., Characterization of Delivery Systems, Differential Scanning Calorimetry, pp. 217-218 (in Encyclopedia of Controlled Drug Delivery, 1999, John Wiley & Sons, pp. 212-227).
Dörwald, F. Zaragoza. Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA, 2005, Preface.
Gunter Rommele et al., “Papulacandins—The Relationship between Chemical structure and effect on Glucan Synthesis in Yeast”, The Journal of Antibiotics, Pharmaceutical Research Laboratories, Ciba- Geigy Limited, Basel, Switzerland, vol. XXXVI, No. 11 pp. 1539-1542, 1983.
Manuel Debono et al., “Semisynthetic Chemical Modification of the Antifungal Lipopeptide Echinocandin B (ECB): Structure- Activity Studies of the Lipophilic and Geometric Parameters of Polyarylated Acyl Analogs of ECB”, J. Med. Chem., 1995, vol. 38, pp. 3271-3281, American Chemical Society.
Otto D. Hensens et al., “Pneumocandins fromZalerion arboricola”, the Journal of Antibiotics, vol. 45, No. 12, pp. 1875-1885, Dept. of Natural Products Chemistry, Merck Research Laboratories, USA, 1992.
Hideo Takeshima et al., “A Deacylation Enzyme for Aculeacin A, a Neutral Lipopeptide Antibiotic fromActinoplanes utahensis: Purification and Characterization”, Journal of Biochemistry, vol. 105, No. 4, 1989, pp. 606-610.
F. Aileen Bouffard et al., “Synthesis and Antifungal Activity of Novel Cationic Pneumocandin B0 Derivatives”, Journal of Medicinal Chemistry, vol. 37, pp. 222-225, 1994, American Chemical Society.
Masaki Tomishima et al., “FK463, a Novel Water- soluble Echinocandin Lipopeptide: Synthesis and Antifungal Activity”, The Journal of Antibiotics, vol., 52, No. 7, Jul. 1999, pp. 674-676.
Ganapathi R. Revankar et al., “Synthesis and Antimicrobial Activity of Certain Imidazo [1,2 -a] pyrimidines”, Journal of Medicinal Chemistry, vol. 18, No. 12, pp. 1253-1255, 1975.
Achiwa Issei
Horiuchi Takao
Kanai Kazuo
Kawakami Katsuhiro
Kobayashi Syozo
Anderson Rebecca L
Coughlin Matthew P
Daiichi Sankyo Company, Limited
Sughrue & Mion, PLLC
LandOfFree
Antifungal bicyclic hetero ring compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antifungal bicyclic hetero ring compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antifungal bicyclic hetero ring compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4201818